Trading Statement
15 Setembro 2008 - 3:00AM
UK Regulatory
RNS Number : 3853D
Bioganix PLC
15 September 2008
Bioganix Plc ("Bioganix" or "the Group")
Trading Update
The Group's trading performance over recent weeks has been disappointing principally for the following reasons:
* Volumes of waste material being processed at Parham have been lower than
expected due to delays in securing a number of key contracts for food
waste.
* The anticipated increase in volumes of waste material being processed at
Sharpness has been slower than expected. Although the Group is continuing
to pitch for new waste material, the Board now considers it likely that
the ramp-up to acceptable levels of operation at Sharpness will take
longer than previously expected.
* Operating costs at both Parham and Sharpness have been generally higher
than expected particularly in respect of chemicals and fuel.
As a result of lower revenues and higher costs, the Group's cash position has deteriorated. The Group is currently trading within its
existing bank overdraft facility and is in discussions with its bankers over providing enhanced facilities.
The Board is continuing to work on securing planning permission for the proposed new Bioganix plant at Aylesbury and continues to
consider options for its financing.
The Company expects to announce its interim results for the six months ended 30 June 2008 on 26 September 2008.
Contacts:
Nick Helme 01568 619 115
Managing Director - Bioganix Plc
Julian Morgan 01568 619 101
Finance and Commercial Director - Bioganix Plc
Mike Coe 0117 933 0020
Blue Oar Securities Plc
Tom Cooper / Paul Vann 020 3043 4162
Winningtons Financial 0797 122 1972
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTEAKNAFAFPEFE
Sofix Ucits Etf (LSE:BGX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Sofix Ucits Etf (LSE:BGX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Sofix Ucits Etf da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Bioganix Plc